Suppliers and packagers for yutiq

yutiq

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Alimera Sciences Inc	YUTIQ	fluocinolone acetonide	IMPLANT;INTRAVITREAL	210331	NDA	ANI Pharmaceuticals, Inc.	68611-180-01	1 POUCH in 1 CARTON (68611-180-01) / 1 APPLICATOR in 1 POUCH / 1 IMPLANT in 1 APPLICATOR	2023-05-17

Suppliers and packagers for yutiq

Last updated: May 29, 2026

YUTIQ suppliers (manufacturers, contract manufacturers, and input sources) for the fluocinolone acetonide intravitreal implant

YUTIQ (fluocinolone acetonide intravitreal implant) is supplied by Alimera Sciences (brand holder). The implant manufacturing supply chain is not fully enumerated in public, consolidated form in a way that can be listed as named CMO/CMR suppliers with reliable attribution from available sources here.

Who supplies YUTIQ (fluocinolone acetonide implant) to the US market?

Alimera Sciences is the pharmaceutical company associated with YUTIQ commercialization in the United States and is the responsible entity for the marketed product.

Which entity is listed as the applicant/labeling manufacturer

YUTIQ’s US labeling ties the marketed product to Alimera Sciences and reflects the party managing regulatory and commercial status for the finished drug.

Does YUTIQ use contract manufacturing

Publicly accessible sources needed to map named contract manufacturers and component suppliers (implant core, applicator, sterile manufacturing, and packaging) are not available in a single, citable dataset in this context.

What company manufactures the YUTIQ intravitreal implant?

YUTIQ is manufactured and supplied as a finished sterile intravitreal implant product under Alimera’s marketed product stewardship.

Drug product vs. device-like components

The intravitreal implant system includes the implant and the applicator/administration-related components. Public, source-citable attribution of each manufacturing step (implant drug substance formulation, sterile fill-finish analogs for implants, applicator assembly, sterilization method vendor) is not available here in a way that supports a supplier table with named entities.

What are the key raw material inputs for YUTIQ (fluocinolone acetonide) and who supplies them?

At the level of public-facing, product-specific supplier identification, the detailed raw-material procurement chain for YUTIQ (API and excipients used in the implant formulation, polymer/implant matrix components, sterilization consumables, and packaging materials) is not available here in a reliably citable, itemized form.

What is the API

The active ingredient is fluocinolone acetonide.

What excipient or implant-matrix suppliers can be named

Named suppliers for the implant matrix, polymer components, and packaging subcomponents are not available in citable form in this context.

How do FDA listings identify YUTIQ suppliers and manufacturing sites?

The FDA labeling and related product listings can show the company responsible for the product and sometimes manufacturing site addresses, but mapping that to named supplier companies beyond the applicant/label owner requires a citable linkage that is not present in this context.

Orange Book listings and manufacturing data

YUTIQ is regulated as a branded ophthalmic drug product with a branded NDA; supplier-by-supplier identification is not provided in the Orange Book in a way that supports a complete supplier roster here.

Are there alternative or competing fluocinolone acetonide implant suppliers (IOP, uveitis, AMD pathways)?

Within the fluocinolone acetonide intravitreal implant category, other branded products may exist in different geographies or under different approvals. Named supplier mapping for those comparators also requires product-specific FDA label and manufacturing site documentation, which is not available in this context.

Supplier risk: what barriers affect YUTIQ supply continuity?

The primary execution risks for intravitreal implant products are:

• sterile manufacturing capacity for ophthalmic products
• constrained lot release timelines and quality system controls for sterile implant manufacturing
• packaging and applicator component availability

Public, named-company dependency mapping is not available here.

Key Takeaways

• Alimera Sciences is the company associated with supplying and commercializing YUTIQ (fluocinolone acetonide intravitreal implant) in the US.
• A complete, named list of API suppliers, excipient/matrix suppliers, and contract manufacturing organizations for the YUTIQ implant and administration system is not available here in a citable, consolidated form.

FAQs

1. Is YUTIQ manufactured by Alimera Sciences or by a contract manufacturer?
   The US marketed product is associated with Alimera Sciences; named contract manufacturers are not itemized in this context.

2. Who supplies the fluocinolone acetonide API used in YUTIQ?
   The active ingredient is fluocinolone acetonide; named API suppliers are not itemized here.

3. Where can I find YUTIQ manufacturing site information?
   FDA product labeling and listings can contain manufacturing site references, but a named supplier roster beyond the label/application entity is not available here.

4. Do applicator/administration system components change YUTIQ’s supplier chain?
   Yes, intravitreal implant delivery systems require integrated components; supplier details are not itemized here.

5. What supply-chain constraints are most likely for YUTIQ?
   Sterile ophthalmic manufacturing, lot release, and availability of implant and administration-system components are the key continuity risks.

References (APA)

1. FDA. (n.d.). YUTIQ prescribing information / product labeling. U.S. Food and Drug Administration.
2. FDA. (n.d.). Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. U.S. Food and Drug Administration.